Navigation Links
Kyowa Hakko Kirin Announces Development Policy for Anti-Parkinson's Disease Drug KW-6002 (Istradefylline)
Date:1/14/2009

TOKYO, Jan. 15 /PRNewswire/ -- Kyowa Hakko Kirin Co., Ltd. (Chiyoda-ku, Tokyo Japan; President, Dr. Yuzuru Matsuda) announced on January 15 (Tokyo Time) that it has decided to continue the domestic development of its proprietary anti-Parkinson's disease drug KW-6002 (generic name: Istradefylline) and move it forward with a Phase 3 clinical trial in Japan.

KW-6002 has a novel mechanism of action that specifically antagonizes the adenosine A2A receptor. Kyowa Hakko Kirin initiated the clinical evaluation of KW-6002 in 1996, and conducted Phase 2 and 3 studies in the US and Europe to assess its efficacy and safety in Parkinson's disease patients who were experiencing wearing-off phenomenon*, a motor complication, while receiving Levodopa therapy alone or in combination with other anti-Parkinson's disease drugs. Based on the results of these studies, the new drug application (NDA) for registration of KW-6002 in the US was submitted to the Food and Drug Administration (FDA) in April 2007. On February 25, 2008, Kyowa received an action letter from the FDA. Subsequent to discussions with FDA, Kyowa decided to await the results of the ongoing Japanese phase 2b study of KW-6002 as adjunctive therapy to Levodopa, and then comprehensively examine and determine a path forward for KW-6002.

The results of the Phase 2b study in Japan have recently become available and demonstrate the efficacy of KW-6002 compared with placebo, warranting further clinical investigation in Japan.

For the development and commercialization of KW-6002 in overseas markets, is pursuing out-licensing opportunities.

We believe that KW-6002 will offer a new therapeutic option for Parkinson's disease and provide clinical benefit to patients suffering from wearing-off phenomenon and other symptoms.

* Parkinson's disease is a progressive neurodegenerative disorder which is characterized by motor symptoms such a
'/>"/>

SOURCE Kyowa Hakko Kirin Co., Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Intra-Cellular Therapies Announces Successful Outcome of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
2. Beactica Announces Fragment-Based Drug Discovery Research Collaboration With GE Healthcare and Uppsala University
3. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
4. NeurogesX Announces Publication of Phase 3 Data for QUTENZA(TM) (NGX-4010) in Postherpetic Neuralgia (PHN) by The Lancet Neurology
5. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
6. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
7. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
8. ProUroCare Medical Inc. Announces Pricing of Equity Offering
9. Quark Pharmaceuticals Announces Dosing of the First Patient in Phase I/II Clinical Trial for Systemically Delivered siRNA Drug Candidate for Delayed Graft Function
10. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
11. Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2014)... S.C. , Dec. 14, 2014  ChartSpan, a ... the most downloaded iPhone and iPad medical app in ... Photo - http://photos.prnewswire.com/prnh/20141214/164317 ChartSpan ... the ability to request, manage and send electronic healthcare ... innovative entrepreneurs who grew tired of waiting for the ...
(Date:12/13/2014)... , Dec. 12, 2014  Radiologists can transmit ... images, to their referring physicians, electronic health records ... carefully selected technology.  That was ... Systems Corporation (ADS) at the recent Radiology Society ... transmitting of radiology reports in this manner also ...
(Date:12/13/2014)... 12, 2014 Research ... addition of the  "Global Capnography Market 2015-2019" ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,Capnography is the ... respiratory gasses during the integral part of ... information about CO2 production, alveolar ventilation, and ...
Breaking Medicine Technology:ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 2Advanced Data Systems Presents on Interface-Free EHR Communications at RSNA's 2014 Conference: Streamlining Communication of Reports and Images to Referring Physicians 3Global Capnography Market 2015-2019: Key Vendors are Covidien, Masimo, Philips Healthcare, Smiths Medical and Welch Allyn 2Global Capnography Market 2015-2019: Key Vendors are Covidien, Masimo, Philips Healthcare, Smiths Medical and Welch Allyn 3
... Mass., Nov. 12, 2010 Royal Philips Electronics (NYSE: ... Lin, Ph.D., research fellow at the Cerebral Vascular Disease ... School of Medicine, has been selected as the recipient ... Award. The $100,000 grant, which is funded ...
... Nov. 12, 2010 EntreMed, Inc. (Nasdaq: ... therapeutics for the treatment of cancer, today reported ... September 30, 2010. (Logo: http://photos.prnewswire.com/prnh/20010620/ENMDLOGO) ... a net loss for the third quarter of ...
Cached Medicine Technology:Philips and American Heart Association Present Fourth Annual Resuscitation Fellowship Award 2EntreMed Reports Third Quarter 2010 Financial Results 2EntreMed Reports Third Quarter 2010 Financial Results 3EntreMed Reports Third Quarter 2010 Financial Results 4
(Date:12/17/2014)... (PRWEB) December 17, 2014 Now in ... celebrate the best of the best in senior living ... is only given to communities and agencies that have ... SeniorAdvisor.com site. Of the nearly 100,000 providers currently listed ... Winners of the SeniorAdvisor.com Best of 2015 Awards are ...
(Date:12/17/2014)... parents should leave prenatal picture-taking to medical professionals, the ... ultrasound imaging and heartbeat monitors to get "keepsake" images ... "Although there is a lack of evidence ... monitors, prudent use of these devices by trained health ... engineer, said in an agency news release. "Ultrasound ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... health, but a growing body of evidence shows the ancient ... In fact, the benefits were similar to those of ... Chu, a doctoral candidate at Harvard University,s Health Policy Program ... that people randomly assigned to take yoga classes saw improvements ...
(Date:12/15/2014)... NV (PRWEB) December 15, 2014 Veretekk.com, ... company, JM Ocean Avenue. JM Ocean Avenue has ... the Veretekk online automated marketing system. JM Ocean ... June 2014 merger of Ocean Avenue and JM International, ... than $2 Billion per year company. , “After nearly ...
(Date:12/15/2014)... MD (PRWEB) December 15, 2014 ... services today released “ Social Media Cheat Sheets ,” ... a community that drives results on the top ten ... marketing program. It helps drive awareness, engagement, and customer ... For marketers to make an impact on new networks ...
Breaking Medicine News(10 mins):Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3
... , RIVERWOODS, Ill., ... has updated three of its Special Tax Briefings on the ... a Wolters Kluwer business and a leading provider of tax, accounting and ... coverage visit CCH Tax Legislation Coverage , or: , for ...
... , PHILADELPHIA, Dec. 22 ... announced today that it has achieved CAQH® Committee on Operating ... certification for its InstaMed Platform and Network product. ... product achieved CORE Phase I certification in June of this ...
... , SHENZHEN, China, ... http://www.htdsmedical.com ) would like to announce that it has an ... a large modern herbal medicine company in China. The buyer, ... herbs, herbal extracts and herbal preparations. Name of the buyer ...
... may be due to other factors , TUESDAY, Dec. ... protein that indicates tissue inflammation in the body to future ... , But the association may be the result of other ... than the protein itself, researchers said. , The molecule, known ...
... slightly fewer behavioral issues among children whose moms took ... The children of women who take low-dose aspirin during ... prematurely might have fewer behavioral problems at age 5, ... to pregnant women who are apt to have such ...
... Central Florida have found a protein that could hold the ... brain tumors in adults. Glioblastoma multiforme (GBM), the type ... Edward Kennedy, is difficult to treat because it spreads cancerous ... 10,000 cases are diagnosed in the United States each year. ...
Cached Medicine News:Health News:CCH Updates Briefings on Tax Provisions of Estate Tax, Tax Extender, Health Care Reform Bills 2Health News:InstaMed Achieves Core Phase II Certification to Streamline Provider Access to Consistent Electronic Eligibility and Claim Status 2Health News:InstaMed Achieves Core Phase II Certification to Streamline Provider Access to Consistent Electronic Eligibility and Claim Status 3Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 2Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 3Health News:Hard to treat Diseases (HTDS) To Sell Its MindUp BioResearch Division 4Health News:Aspirin During Pregnancy May Help Preemies 2Health News:Aspirin During Pregnancy May Help Preemies 3
Visionary OFFICE™ PM offers a Windows interface featuring medical billing, appointment scheduling and patient information....
... The OmniMD Medical Billing system allows ... and accounting. It is integrated with ... capture. The system interfaces with electronic ... tracking. With a set of reports, ...
... Amylase CPNG3 single liquid stable reagent ... of single liquid stability to help ... and provide quick result turnaround time. ... Amylase CPNG3 reagent provides a long ...
... single liquid stable reagent offers the ... liquid stability to help maximize laboratory ... quick result turnaround time. The proprietary ... reagent provides a long shelf life ...
Medicine Products: